Skip to main content

Advertisement

SpringerLink
Log in

Biochemical Markers of Bone Turnover in Percutaneous Vertebroplasty for Osteoporotic Compression Fracture

  • Clinical Investigation
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate relationships between biochemical markers of bone turnover, bone mineral density, and new compression fractures following vertebroplasty.

Methods

Initially, we enrolled 30 consecutive patients with vertebral compression fractures caused by osteoporosis. Twenty-three of the 30 patients visited our hospital for follow-up examinations for more than 4 weeks after vertebroplasty. The patients were divided into two groups: patients with new fractures (group F) and patients with no new fractures (group N). We analyzed differences in the following parameters between these two groups: serum bone alkaline phosphatase, urinary crosslinked N-telopeptide of type I collagen, urinary deoxypyridinoline, and bone mineral density. Next, the patients were divided into another two groups: patients with higher risk (group H: urinary crosslinked N-telopeptide of type I collagen >54.3 nmol BCE/mmol Cr or urinary deoxypyridinoline >7.6 nmol/mmol Cr, and serum bone alkaline phosphatase <29.0 U/l) and patients with lower risk (group L). We analyzed the difference in the rate of new fractures between these two groups.

Results

We identified 9 new fractures in 7 patients. There were no significant differences between groups F and N. We identified 5 new fractures in 3 of the 4 patients in group H, and 4 new fractures in 4 of the 19 patients in group L. There was a significant difference in the rate of new fractures between groups H and L.

Conclusions

A combination of high levels of bone resorption markers and normal levels of bone formation markers may be associated with increased risk of new recurrent fractures after percutaneous vertebroplasty.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cotten A, Boutry N, Cortet B et al. (1998) Percutaneous vertebroplasty: State of the art. Radiographics 18:311–323

    PubMed  CAS  Google Scholar 

  2. Peh WC, Gilula LA, Peck DD (2002) Percutaneous vertebroplasty for severe osteoporotic vertebral body compression fractures. Radiology 223:121–126

    Article  PubMed  Google Scholar 

  3. Kallmes DF, Jensen ME (2003) Percutaneous vertebroplasty. Radiology 229:27–36

    Article  PubMed  Google Scholar 

  4. Grados F, Depriester C, Cayrolle G et al. (2000) Long-term observations of vertebral osteoporotic fractures treated by percutaneous vertebroplasty. Rheumatology (Oxford) 39:1410–1414

    Article  CAS  Google Scholar 

  5. Uppin AA, Hirsch JA, Centenera LV et al. (2003) Occurrence of new vertebral body fracture after percutaneous vertebroplasty in patients with osteoporosis. Radiology 226:119–124

    Article  PubMed  Google Scholar 

  6. Lin EP, Ekholm S, Hiwatashi A et al. (2004) Vertebroplasty: Cement leakage into the disc increases the risk of new fracture of adjacent vertebral body. AJNR Am J Neuroradiol 25:175–180

    PubMed  Google Scholar 

  7. Komemushi A, Tanigawa N, Kariya S et al. (2006) Percutaneous vertebroplasty for osteoporotic compression fracture: Multivariate study of predictors of new vertebral body fracture. Cardiovasc Intervent Radiol 29:580–585

    Article  PubMed  Google Scholar 

  8. Nishizawa Y, Nakamura T, Ohta H et al. (2005) Guidelines for the use of biochemical markers of bone turnover in osteoporosis (2004). J Bone Miner Metab 23:97–104

    Article  PubMed  Google Scholar 

  9. Weinstein RS (2000) True strength. J Bone Miner Res 15:621–625

    Article  PubMed  CAS  Google Scholar 

  10. Chesnut CH 3rd, Rosen CJ, Bone Quality Discussion Group (2001) Reconsidering the effects of antiresorptive therapies in reducing osteoporotic fracture. J Bone Miner Res 16:2163–2172

    Article  PubMed  CAS  Google Scholar 

  11. Tanigawa N, Komemushi A, Kariya S et al. (2005) Intraosseous venography with carbon dioxide contrast agent in percutaneous vertebroplasty. AJR Am J Roentgenol 184:567–570

    PubMed  Google Scholar 

  12. Leibold RA, Gilula LA (2002) Sterilization of barium for vertebroplasty: An effective, reliable, and inexpensive method to sterilize powders for surgical procedures. AJR Am J Roentgenol 179:198–200

    PubMed  Google Scholar 

  13. Maehara M, Tanigawa N, Ikeda K et al. (2006) Gadolinium-enhanced magnetic resonance imaging after percutaneous vertebroplasty does not improve the short-term prediction of new compression fractures. Acta Radiol 47:817–822

    Article  PubMed  CAS  Google Scholar 

  14. Lindsay R, Silverman SL, Cooper C et al. (2001) Risk of new vertebral fracture in the year following a fracture. JAMA 285:320–323

    Article  PubMed  CAS  Google Scholar 

  15. Delmas PD, Ensrud KE, Adachi JD et al. (2002) Multiple Outcomes of Raloxifene Evaluation Investigators. Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: Four-year results from a randomized clinical trial. J Clin Endocrinol Metab 87:3609–3617

    Article  PubMed  CAS  Google Scholar 

  16. Hulme PA, Krebs J, Ferguson SJ et al. (2006) Vertebroplasty and kyphoplasty: A systematic review of 69 clinical studies. Spine 31:1983–2001

    Article  PubMed  Google Scholar 

  17. Cummings SR, Karpf DB, Harris F et al. (2002) Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med 112:281–289

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Kansai Medical University, 2-3-1 Shinmachi, Hirakata, Osaka, 573-1191, Japan

    Atsushi Komemushi, Noboru Tanigawa, Shuji Kariya, Hiroyuki Kojima, Yuzo Shomura, Takanori Tokuda, Motoo Nomura, Jiro Terada, Minoru Kamata & Satoshi Sawada

Authors
  1. Atsushi Komemushi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Noboru Tanigawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shuji Kariya
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hiroyuki Kojima
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yuzo Shomura
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Takanori Tokuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Motoo Nomura
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jiro Terada
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Minoru Kamata
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Satoshi Sawada
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Atsushi Komemushi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Komemushi, A., Tanigawa, N., Kariya, S. et al. Biochemical Markers of Bone Turnover in Percutaneous Vertebroplasty for Osteoporotic Compression Fracture. Cardiovasc Intervent Radiol 31, 332–335 (2008). https://doi.org/10.1007/s00270-007-9246-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-007-9246-8

Keywords

Search

Navigation